
James D. Chalmers, MBChB, PhD
Advertisement
James Chalmers, MBChB, PhD, is Asthma and Lung UK Chair of Respiratory Medicine at the School of Medicine, University of Dundee.
Articles by James D. Chalmers, MBChB, PhD


This interview highlights the subgroup analysis findings of the ASPEN trial, specifically on brensocatib for non-cystic fibrosis bronchiectasis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Single Annual Injection Produces Significant and Sustained Lp(a) Reductions
2
Ruvonoflast Reduces hsCRP, Inflammation, CVD Risk With Downstream Effects
3
Lessons From ZEUS on Targeting Inflammation, With Peter Libby, MD
4
SUMMIT Substudy Reveals Tirzepatide’s Impact on LV, Atrial Metrics of HFpEF
5
